Veracyte Announces That Data From Two Significant Phase III Clinical Trials Using Its Prosigna Breast And Decipher Prostate Tests Will Be Presented At The 2026 Asco Annual Meeting; Additional Data From ENZAMET Study Show How Decipher Can Help Metastatic Prostate Cancer Patients Avoid Unnecessary Treatment And Enable More Personalized Care